Cartesian Therapeutics, Inc. (RNAC)

Last Closing Price: 10.00 (2025-05-29)

Earnings Announcements: Estimated vs Actual

On 2025-05-08, Cartesian Therapeutics, Inc. (RNAC) announced earnings per share of $-0.68 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.61.

The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.77 for the fiscal quarter ending 2025-06-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.

Announcement Date Fiscal Quarter End Estimated EPS Actual EPS
2025-05-08 2025-03-31 $-0.61 $-0.68
2024-11-07 2024-09-30 $-0.78 $-0.69
2024-08-08 2024-06-30 $-0.81 $0.54
2024-05-08 2024-03-31 $-0.81 $-1.97
2024-03-07 2023-12-31 $-0.30 $-2.40
2023-11-13 2023-09-30 $-2.10 $-2.40
2023-08-17 2023-06-30 $-2.70 $-2.10
2023-05-04 2023-03-31 $-2.40 $-3.30
2023-03-02 2022-12-31 $-1.20 $-0.90
2022-11-03 2022-09-30 $0.30 $-0.30
2022-08-04 2022-06-30 $-0.90 $1.80
2022-05-05 2022-03-31 $-2.70 $-2.10
2022-03-10 2021-12-31 $-2.10 $-1.20
2021-11-09 2021-09-30 $-2.10 $-4.80
2021-08-12 2021-06-30 $-2.70 $-1.20
2021-05-13 2021-03-31 $-3.60 $-6.61
2021-03-11 2020-12-31 $-4.50 $-4.20
2020-11-05 2020-09-30 $-3.60 $-2.70
2020-08-06 2020-06-30 $9.61 $-5.11
2020-05-07 2020-03-31 $-8.11 $-6.31
2020-03-12 2019-12-31 $-5.71 $-8.41
2019-11-08 2019-09-30 $-8.41 $-7.81
2019-08-08 2019-06-30 $-10.21 $-11.11
2019-05-09 2019-03-31 $-11.11 $-9.31
2019-03-15 2018-12-31 $-22.82 $-19.52
2018-11-08 2018-09-30 $-23.72 $-21.32
2018-08-08 2018-06-30 $-21.62 $-25.23
2018-05-09 2018-03-31 -- $-21.32
2018-03-15 2017-12-31 $0.00 $-26.43
2017-11-07 2017-09-30 $-26.43 $-19.82
2017-08-11 2017-06-30 $-25.83 $-25.53
2017-05-11 2017-03-31 -- $-24.62
2017-03-27 2016-12-31 $9.61 $-23.12
2016-11-10 2016-09-30 $-14.41 $-12.91
2016-08-09 2016-06-30 $-13.51 $-82.58